MyFinsight
Home
Blog
About
Contact
Proceeds from maturities
and sales of...
$40,720K
Proceeds from exercise of
stock options
$875K
Proceeds from shares
issued under the...
$218K
Proceeds from sale of
property and equipment
$2K
Net cash provided by
(used in) investing...
$9,818K
Net cash provided by
financing activities
$1,093K
Effect of exchange rate
changes on cash and cash...
$408K
Canceled cashflow
$30,904K
Net decrease in cash
and cash...
-$39,887K
Canceled cashflow
$11,319K
Share-based compensation
expense
$3,726K
Accrued liabilities
$3,358K
Accounts payable
$1,622K
Accounts receivable, net
-$776K
Depreciation and
amortization
$704K
Operating lease
liabilities
$54K
Loss on disposal of
property and equipment
-$37K
Contract liabilities
$3K
Purchases of short-term
investments
$30,470K
Purchases of property and
equipment
$434K
Net cash used in
operating activities
-$51,206K
Canceled cashflow
$10,280K
Other income, net
$2,791K
License and
collaboration revenues
$64K
Net loss
-$55,480K
Canceled cashflow
$2,855K
Prepaid expenses and
other current assets
$4,110K
Accretion of discounts on
available-for-sale investments
$773K
Other non-current
assets
$605K
Other non-current
liabilities
-$518K
Research and development
expense
$37,798K
General and
administrative expense
$20,340K
Income tax expense
$197K
Back
Back
Cash Flow
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)
source: myfinsight.com